Paired box gene 5: Difference between revisions
Jump to navigation
Jump to search
starter |
m update image |
||
| Line 1: | Line 1: | ||
{{ Infobox immunostain | {{ Infobox immunostain | ||
| Name = {{PAGENAME}} | | Name = {{PAGENAME}} | ||
| Image = | | Image = PAX5_immunohistochemistry_in_relapsed_classical_Hodgkin's_lymphoma.jpg | ||
| Width = | | Width = | ||
| Caption = PAX5 staining in a classical Hodgkin's lymphoma | | Caption = PAX5 staining in a classical Hodgkin's lymphoma | ||
Latest revision as of 12:57, 14 November 2020
| Paired box gene 5 | |
|---|---|
| Immunostain in short | |
 PAX5 staining in a classical Hodgkin's lymphoma | |
| Abbreviation | PAX5 |
| Use | B-cell marker, weakly positive in classical Hodgkin's lymphoma |
| Subspeciality | hematopathology |
| Normal staining pattern | nuclear stain |
| Positive | B-cell lymphoma, classical Hodgkin's lymphoma |
Paired box gene 5, commonly known by the abbreviation PAX5, is a immunostain used in hematopathology.
Tumours with positive staining
- B-cell lymphomas
- Hodgkin lymphoma
- typically weak in classical Hodgkin's lymphoma
- strong in nodular lymphocyte-predominant Hodgkin's lymphoma
Negative staining
- Plasmablastic neoplasms